GenHealth.ai
AI agents automate administrative and revenue-cycle workflows for healthcare providers, DME suppliers and health plans.
$16.5MSeries A
ParticipantA
ARTIS
av.co ↗Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
ARTIS invests in frontier technology and healthcare businesses. Explore its stated focus and recorded funding activity in patient data and healthcare operations.
Investment approach
ARTIS is a San Francisco investment firm backing founders applying frontier technologies to health and other systems essential to human life. Its official portfolio groups investments across TechBio, technology and health, and frontier technology. The firm emphasizes scientific and technological advances that can make healthcare more proactive, personalized and resilient.
Recorded funding activity
Its recorded activity on RoundOS includes Metriport and GenHealth.ai. ARTIS lists Metriport in its official portfolio and has publicly confirmed backing GenHealth's Series A. The two companies address different healthcare infrastructure problems: connecting patient records and completing medical administrative workflows. These are examples from the financing histories covered here, rather than a complete ARTIS portfolio.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $42.5M 2 disclosed · full round size, not this investor’s share